Latest Alcohols Stories
DUBLIN, March 24, 2015 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/t4crxd/global) has announced the addition of the "Global Astaxanthin
Enteric-Coated Buprenorphine Product Candidates (BuTab, REL-1028) to be Compared with Marketed Intravenous and Sublingual Formulations NEW YORK, March 24, 2015 /PRNewswire/ -- Relmada
In a recent bill approved by West Virginia, Naloxone will be available to everyone in need of treating a victim of an opiate overdose, according to a recent article by Metro News.
A new form of Naltrexone, Vivitrol, has been proven effective in treating nearly every patient prescribed the opiate blocking medication by the Washington County Health Department, according to
SAN FRANCISCO, March 19, 2015 /PRNewswire/ -- Nektar Therapeutics (NASDAQ: NKTR) reported that partner AstraZeneca today announced a co-commercialisation agreement with Daiichi Sankyo, Inc.
PARSIPPANY, N.J., March 19, 2015 /PRNewswire/ -- Daiichi Sankyo, Inc.
To Spotlight Brain Health Awareness Week, Cognizin® Citicoline Releases Consumer Brain Health Survey Results NEW YORK, March 18, 2015 /PRNewswire/ -- To bring much-needed attention
Harbor Village Detox comments on the effectiveness of naltrexone, which is a non opiate based drug helping drug addicts to overcome heroin addiction and opiate abuse.
DALLAS, March 17, 2015 /PRNewswire/ -- RnRMarketResearch.com adds "Linzess (Irritable Bowel Syndrome) - Forecast and Market Analysis to 2023" market research report provides
- Emitting flashes of light; glittering.
More Images (1 images) »